Palladin, Cytoskeletal Associated Protein (PALLD) (Middle Region) Peptide
PALLD
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all PALLD products
- PALLD (Palladin, Cytoskeletal Associated Protein (PALLD))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- RRPRSRSRDS GDENEPIQER FFRPHFLQAP GDLTVQEGKL CRMDCKVSGL
- Characteristics
- This is a synthetic peptide designed for use in combination with anti- PALLD Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- PALLD (Palladin, Cytoskeletal Associated Protein (PALLD))
- Background
-
This gene encodes a cytoskeletal protein that is required for organizing the actin cytoskeleton. The protein is a component of actin-containing microfilaments, and it is involved in the control of cell shape, adhesion, and contraction. Polymorphisms in this gene are associated with a susceptibility to pancreatic cancer type 1, and also with a risk for myocardial infarction. Alternative splicing results in multiple transcript variants.
Alias Symbols: MYN, PNCA1, CGI151, SIH002, CGI-151
Protein Size: 777 - Gene ID
- 23022
- NCBI Accession
- NM_001166108, NP_001159580
-
You are here:
